MedTrace Logo

Intralipid Related Effect on NKcells in Patients With Unexplained Recurrent Spontaneous Abortion

NCT03132779 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2017-04-28

No results posted yet for this study

Summary

Evaluating the effect of intralipid on the natural killer cells

Conditions

  • Recurrent Miscarriage

Interventions

DRUG

Intralipid

Adose of intralipid given and rechecking NKcells activity

Sponsors & Collaborators

  • Ain Shams Maternity Hospital

    collaborator OTHER

  • Ahmed Mohamed Bahaa Eldin Ahmed

    lead OTHER

Principal Investigators

  • Hassan T Khairy, Professor · Hassan Tawfik office

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
38 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-01
Primary Completion
2018-01-20
Completion
2018-02-20

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03132779 on ClinicalTrials.gov